查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363067

胃肠滞留给药系统外包市场规模、份额和趋势分析报告：按剂型、地区和细分市场预测，2023-2030年

Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 175 Pages | 商品交期: 2-10个工作天内

价格

胃肠滞留给药系统外包市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球胃肠道滞留给药系统外包市场规模将达22.7亿美元。

预计2023年至2030年该市场将以6.99%的年复合成长率扩张。对以患者为中心的解决方案的日益关注和对外包的需求不断增长是推动市场扩张的一些关键要素。此外，对局部药物输送的日益关注预计将促进市场成长。

胃肠滞留药物递送系统适用用途胃肠道内的局部药物递送。对于消化性溃疡、食道症 (GERD) 和发炎性肠道疾病(IBD) 等疾病尤其如此。此外，奈米技术、3D 列印和数数位健康等先进技术正在胃滞留药物输送系统中探索，以提高药物传输准确性、监测和患者参与度。

COVID-19大流行对胃肠道滞留给药系统外包市场产生了重大影响。由于封锁、旅行限制和患者招募问题，许多临床试验被推迟或推迟。这阻碍了新型胃滞留药物输送系统的开发和测试。此外，疫情扰乱了全球供应链，导致原料和工业零件取得困难。此要素影响了胃肠滞留给药系统的生产和发展。

要素营运公司推出新产品、併购策略性措施不断增加，以及研发项目投资增加等因素预计也将推动未来年度的市场成长。例如，2022 年 11 月，Lonza 宣布推出 Capsugel Enprotect，这是一种专为肠内给药而设计的新型胶囊解决方案。与传统胶囊不同，这种创新设计在通过胃的过程中保持完整，仅在肠道中释放其内容物。 Capsugel Enprotect 是一种无涂层胶囊，由于不需要涂层或密封胶囊，因此有可能简化药品製造流程。

胃肠滞留给药系统外包市场报告重点

  • 以剂型划分，锭剂占据最大的销售份额，2022 年将超过 38%。锭剂是众所周知且广泛使用的剂型。由于锭剂适应性强，可用于控制释放、缓释、标靶给药等多种製剂方式，是胃滞留给药系统的理想选择。
  • 预计胶囊在预测期内将占据重要的市场占有率。改良释放和特殊涂层等胶囊技术的发展允许开发更先进的胃滞留组合物。这些进步可能会增加对以胶囊给药系统为中心的外包服务的需求。
  • 2022 年，北美地区的销售份额最大，超过 47%。这得归功于该地区先进的医药产业、强大的研发能力、高市场需求和完善的医疗基础设施。
  • 同时，亚太地区预计将在未来年度对市场收益做出重大贡献。具有成本效益的外包、政府的支持和激励、不断增长的医疗保健需求以及技术进步是推动该地区市场成长的关键要素。

目录

第1章调查方法和范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 市场趋势及展望
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 营商环境分析
    • PESTLE分析
    • 波特五力分析
  • COVID-19感染疾病的影响分析

第4章业务分析

  • 胃肠滞留给药系统外包：2022 年及 2030 年剂型变化分析
  • 锭剂
  • 液体
  • 微球
  • 胶囊
  • 其他的

第5章区域业务分析

  • 区域市场简介
  • 北美洲
    • 2018-2030年北美胃肠滞留给药系统外包市场
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲胃肠滞留给药系统外包市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区胃肠滞留给药系统外包市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲胃肠滞留给药系统外包市场，2018-2030
    • 主要国家趋势
    • 法律规范
    • 竞争场景
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA胃肠滞留给药系统外包市场，2018-2030年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第6章竞争形势

  • 公司分类
  • 策略规划
    • 收购
    • 合作
    • 宣布新平台
    • 其他的
  • 公司简介/名单
    • Catalent
    • Lonza
    • Evonik
    • Colorcon
    • Quotient Sciences
    • Aptar Pharma
    • Aenova Group
    • Evotec
    • Ashland
    • Vectura Group Ltd.
Product Code: GVR-4-68040-122-6

Gastroretentive Drug Delivery Systems Outsourcing Market Growth & Trends:

The global gastroretentive drug delivery systems outsourcing market size is expected to reach USD 2.27 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 6.99% from 2023 to 2030. Rising focus on patient-centric solutions and growing outsourcing demand are some of the key factors driving market expansion. Furthermore, an increased focus on localized drug delivery is expected to boost market growth.

Gastroretentive drug delivery systems are indicated for localized drug delivery applications in the gastrointestinal tract. This is particularly true for disorders such as peptic ulcers, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD). Moreover, the use of advanced technologies such as nanotechnology, 3D printing, and digital health in gastroretentive drug delivery systems has been investigated in order to improve drug delivery accuracy, monitoring, and patient involvement.

The COVID-19 pandemic significantly impacted the market for gastroretentive drug delivery systems outsourcing. Many clinical trials were postponed or delayed as a result of lockdowns, travel restrictions, and patient recruitment issues. This hampered the development and testing of novel gastroretentive medication delivery systems. Moreover, the pandemic disrupted worldwide supply chains, disrupting the availability of raw materials and industrial components. This factor had an influence on the manufacturing and development of gastroretentive drug delivery systems.

Factors such as rising strategic initiatives in the form of new product launches, partnerships, mergers & acquisitions by key operating companies, and growing investments in R&D programs are other factors expected to boost market growth in the coming years. For instance, in November 2022, Lonza introduced a new capsule solution known as Capsugel Enprotect, designed for intestinal drug delivery. Unlike conventional capsules, this innovative design remains intact during stomach transit and only releases its contents in the intestine. Capsugel Enprotect is a coating-free capsule that could potentially simplify the drug manufacturing process by eliminating the need for additional capsule coating or sealing.

Gastroretentive Drug Delivery Systems Outsourcing Market Report Highlights:

  • Based on dosage form, the tablets segment accounted for the largest revenue share of over 38% in 2022. Tablets are a well-known and extensively used dosage type. Because of their adaptability, they can be used in various formulation methods, such as controlled release, sustained release, and targeted administration, making them ideal for gastroretentive drug delivery systems
  • The capsule segment is expected to account for a significant market share in the forecast period. Capsule technology developments, such as modulated release and specialized coatings, enable the development of more advanced gastroretentive compositions. These advancements may enhance the demand for outsourcing services centered on capsule-based medication delivery systems
  • North America captured the largest revenue share of over 47% in 2022. This is attributed to the region's advanced pharmaceutical industry, strong research and development capabilities, high market demand, and an established healthcare infrastructure
  • On the other hand, the Asia Pacific region is expected to contribute significantly to the market revenue in the coming years. Cost-effective outsourcing, government support and incentives, rising healthcare needs, and technological advancements are some of the major factors driving the regional market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Dosage Form Business Analysis

  • 4.1. Gastroretentive Drug Delivery Systems Outsourcing: Dosage Form Movement Analysis, 2022 & 2030
  • 4.2. Tablets
    • 4.2.1. Tablets Market, 2018 - 2030 (USD Million)
  • 4.3. Liquid
    • 4.3.1. Liquid Market, 2018 - 2030 (USD Million)
  • 4.4. Microspheres
    • 4.4.1. Microspheres Market, 2018 - 2030 (USD Million)
  • 4.5. Capsule
    • 4.5.1. Capsule Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Market Snapshot
  • 5.2. North America
    • 5.2.1. North America Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.2.2.2. Key Country Dynamics
      • 5.2.2.3. Regulatory Framework
      • 5.2.2.4. Competitive Scenario
    • 5.2.3. Canada
      • 5.2.3.1. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.2.3.2. Key Country Dynamics
      • 5.2.3.3. Regulatory Framework
      • 5.2.3.4. Competitive Scenario
  • 5.3. Europe
    • 5.3.1. Europe Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.3.2. Germany
      • 5.3.2.1. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.2.2. Key Country Dynamics
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. Competitive Scenario
    • 5.3.3. UK
      • 5.3.3.1. UK Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.3.2. Key Country Dynamics
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Competitive Scenario
    • 5.3.4. France
      • 5.3.4.1. France Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.4.2. Key Country Dynamics
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Competitive Scenario
    • 5.3.5. Italy
      • 5.3.5.1. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.5.2. Key Country Dynamics
      • 5.3.5.3. Regulatory Framework
      • 5.3.5.4. Competitive Scenario
    • 5.3.6. Spain
      • 5.3.6.1. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.6.2. Key Country Dynamics
      • 5.3.6.3. Regulatory Framework
      • 5.3.6.4. Competitive Scenario
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.7.2. Key Country Dynamics
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Competitive Scenario
    • 5.3.8. Sweden
      • 5.3.8.1. Sweden Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.8.2. Key Country Dynamics
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Competitive Scenario
    • 5.3.9. Norway
      • 5.3.9.1. Norway Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.9.2. Key Country Dynamics
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Competitive Scenario
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.2.2. Key Country Dynamics
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Competitive Scenario
    • 5.4.3. China
      • 5.4.3.1. China Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.3.2. Key Country Dynamics
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Competitive Scenario
    • 5.4.4. India
      • 5.4.4.1. India Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.4.2. Key Country Dynamics
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Competitive Scenario
    • 5.4.5. South Korea
      • 5.4.5.1. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.5.2. Key Country Dynamics
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Competitive Scenario
    • 5.4.6. Australia
      • 5.4.6.1. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.6.2. Key Country Dynamics
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Competitive Scenario
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.7.2. Key Country Dynamics
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Competitive Scenario
  • 5.5. Latin America
    • 5.5.1. Latin America Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.5.2. Key Country Dynamics
    • 5.5.3. Regulatory Framework
    • 5.5.4. Competitive Scenario
    • 5.5.5. Brazil
      • 5.5.5.1. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.5.2. Key Country Dynamics
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Competitive Scenario
    • 5.5.6. Mexico
      • 5.5.6.1. Mexico Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.6.2. Key Country Dynamics
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Competitive Scenario
    • 5.5.7. Argentina
      • 5.5.7.1. Argentina Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.7.2. Key Country Dynamics
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. Competitive Scenario
  • 5.6. MEA
    • 5.6.1. MEA Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.2.2. Key Country Dynamics
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Competitive Scenario
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.3.2. Key Country Dynamics
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Competitive Scenario
    • 5.6.4. UAE
      • 5.6.4.1. UAE Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.4.2. Key Country Dynamics
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Competitive Scenario
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.5.2. Key Country Dynamics
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Competitive Scenario

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
    • 6.2.1. Acquisitions
    • 6.2.2. Collaborations
    • 6.2.3. New Platform Launches
    • 6.2.4. Others
  • 6.3. Company Profiles/Listing
    • 6.3.1. Catalent
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Financial Performance
      • 6.3.1.3. Platform Benchmarking
      • 6.3.1.4. Strategic Initiatives
    • 6.3.2. Lonza
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Financial Performance
      • 6.3.2.3. Platform Benchmarking
      • 6.3.2.4. Strategic Initiatives
    • 6.3.3. Evonik
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Financial Performance
      • 6.3.3.3. Platform Benchmarking
      • 6.3.3.4. Strategic Initiatives
    • 6.3.4. Colorcon
      • 6.3.4.1. Company Overview
      • 6.3.4.2. Financial Performance
      • 6.3.4.3. Platform Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Quotient Sciences
      • 6.3.5.1. Company Overview
      • 6.3.5.2. Financial Performance
      • 6.3.5.3. Platform Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. Aptar Pharma
      • 6.3.6.1. Company Overview
      • 6.3.6.2. Financial Performance
      • 6.3.6.3. Platform Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Aenova Group
      • 6.3.7.1. Company Overview
      • 6.3.7.2. Financial Performance
      • 6.3.7.3. Platform Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Evotec
      • 6.3.8.1. Company Overview
      • 6.3.8.2. Financial Performance
      • 6.3.8.3. Platform Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Ashland
      • 6.3.9.1. Company Overview
      • 6.3.9.2. Financial Performance
      • 6.3.9.3. Platform Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Vectura Group Ltd.
      • 6.3.10.1. Company Overview
      • 6.3.10.2. Financial Performance
      • 6.3.10.3. Platform Benchmarking
      • 6.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 4 Global Gastroretentive Drug Delivery Systems Outsourcing Market by Region, 2018 - 2030 (USD Million)
  • Table 5 North America Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 6 North America Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 7 U.S. Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 8 Canada Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 9 Europe Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 10 Europe Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 11 Germany Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 12 UK Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 13 France Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 14 Italy Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 15 Spain Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 16 Denmark Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 17 Sweden Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 18 Norway Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 21 China Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 22 Japan Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 23 India Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 24 South Korea Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 25 Australia Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 26 Thailand Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 27 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 28 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 29 Brazil Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 30 Mexico Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 31 Argentina Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 34 South Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 36 UAE Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 37 Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Gastroretentive Drug Delivery Systems Outsourcing Market, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Tablets,2018 - 2030 (USD Million)
  • Fig. 16 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Liquid,2018 - 2030 (USD Million)
  • Fig. 17 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Microspheres,2018 - 2030 (USD Million)
  • Fig. 18 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Capsule,2018 - 2030 (USD Million)
  • Fig. 19 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Others,2018 - 2030 (USD Million)
  • Fig. 20 Regional Outlook, 2021 & 2030
  • Fig. 21 North America Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 23 Canada Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 24 Europe Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 25 Germany Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 26 UK Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 27 France Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 28 Italy Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 29 Spain Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 30 Denmark Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 31 Sweden Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 32 Norway Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 33 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 34 Japan Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 35 China Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 36 India Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 37 Australia Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 38 South Korea Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 39 Thailand Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 40 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 41 Brazil Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 43 Argentina Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 44 Middle East and Africa Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 45 South Africa Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 46 Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 47 UAE Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 48 Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)